All in Healthcare

Supply Chains and Counterfeit Drugs

Supply Chains and Counterfeit Drugs

Kofo Are
Healthcare

According the World Health Organisation (WHO) counterfeit drugs are estimated to have kill 250,000 children a year. With an estimated 1 million adults suffering a similar fate. Counterfeit drugs have also contributed to an increase in drug resistance in treating serious global diseases.

Counterfeiting is a high-volume high profit business the poses health risks, infringes on intellectual property rights, medicines legislation and other aspects of criminal law. Indirect impacts are loss of revenue for pharmaceutical companies, brand damage and decreased public confidence.

AI, in Bioactivity Prediction to aid Drug Discovery

AI, in Bioactivity Prediction to aid Drug Discovery

Kofo Are
Healthcare

The current cost of developing a new drug is approximately US$2.5b. This number has been steadily on the rise, nearly doubling every nine years. According to Frost and Sullivan AI has the potential to improve outcomes for medical imaging and diagnosis process by 30-40% and reduce costs of treatments by as much as 50%, with a greater impact on patients as a result of earlier diagnosis.